E. Tayar and D. Kodali, “Delayed-onset vitiligo in metastatic HR+/HER2– breast cancer during long-term ribociclib therapy”., EJCRIM, vol. 13, no. 1, Dec. 2025, doi: 10.12890/2025_006043.